1073477-74-3

Basic information

• Product Name: 2-Fluoro-4-(trifluoroMethoxy)phenol
• Synonyms: 2-Fluoro-4-(trifluoroMethoxy)phenol
• CAS NO: 1073477-74-3
• Molecular Formula: C₇H₄F₄O₂
• Molecular Weight: 196.0990728
• Mol File: 1073477-74-3.mol

Chemical Properties

• Boiling Point: 156.7±35.0 °C(Predicted)
• Appearance: /
• Density: 1.480±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 8.10±0.18(Predicted)
• CAS DataBase Reference: 2-Fluoro-4-(trifluoroMethoxy)phenol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Fluoro-4-(trifluoroMethoxy)phenol(1073477-74-3)
• EPA Substance Registry System: 2-Fluoro-4-(trifluoroMethoxy)phenol(1073477-74-3)

Safety Data

• Hazardous Substances Data: 1073477-74-3(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-Fluoro-4-(trifluoromethoxy)phenol is used as a building block for the development of bioactive molecules due to its ability to accept hydrogen bonds, which can enhance the compound's interaction with biological targets and improve its therapeutic potential.
Used in Chemical Research:
2-Fluoro-4-(trifluoroMethoxy)phenol serves as a valuable research tool in the study of fluorinated aryl compounds and their reactivity, as well as their potential applications in various chemical processes and reactions.

Upstream product

• 1073477-73-2 2-(2-fluoro-4-(trifluoromethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 123572-58-7 2-fluoro-4-(trifluoromethoxy)aniline 
• 1077-01-6 meta-fluoro(trifluoromethoxy)benzene 
• 123572-64-5 2-fluoro-1-nitro-4-(trifluoromethoxy) benzene 
• 503309-10-2 (2-fluoro-4-(trifluoromethoxy)phenyl)boronic acid 
• 168971-68-4 1-bromo-2-fluoro-4-(trifluoromethoxy)benzene 

Relevant articles and documents

6-OXO-1,6-DIHYDROPYRIDAZINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF

A 6-oxo-1,6-dihydropyridazine derivative, a preparation method therefor and medical use thereof, in particular, a 6-oxo-1,6-dihydropyridazine derivative represented by general formula (I), a preparation method therefor, and a pharmaceutical composition containing the derivative, and use thereof as a NaV inhibitor and use thereof in the preparation of a drug for the treatment and/or prevention of pain and pain-related diseases. Each substituent in general formula (I) is the same as defined in the description.

Novel Cyclopropabenzofuranyl Pyridopyrazinediones

Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I wherein X, R1, R2a, R2b, R4a, R4b, R5a, R5b, R6, R7, R10, R11, and y are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

PYRIMIDINONE DERIVATIVES AND METHODS OF USE THEREOF

The present invention relates to Pyrimidinone Derivatives, compositions comprising a Pyrimidinone Derivative, and methods of using the Pyrimidinone Derivatives for treating or preventing obesity, diabetes, a metabolic disorder, a cardiovascular disease or a disorder related to the activity of G protein-coupled receptor 119 ("GPR119") in a patient.